VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30000739 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
TVIS30031392 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
TVIS44017284 | HTLV-1 | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CD3D |
---|---|
DrugBank ID | DB16684 |
Drug Name | Odronextamab |
Target ID | BE0010202 |
UniProt ID | P20963 |
Regulation Type | binder |
PubMed IDs | 32521386; 26659273 |
Citations | Tun AM, Ansell SM: Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies. Cancer Treat Rev. 2020 Aug;88:102042. doi: 10.1016/j.ctrv.2020.102042. Epub 2020 May 30.@@Smith EJ, Olson K, Haber LJ, Varghese B, Duramad P, Tustian AD, Oyejide A, Kirshner JR, Canova L, Menon J, Principio J, MacDonald D, Kantrowitz J, Papadopoulos N, Stahl N, Yancopoulos GD, Thurston G, Davis S: A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Sci Rep. 2015 Dec 11;5:17943. doi: 10.1038/srep17943. |
Groups | Investigational |
Direct Classification | Peptides |
SMILES | |
Pathways | |
PharmGKB | |
ChEMBL |